NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 2 FDA
NCT01829711 2020-04-08Moxetumomab Pasudotox for Advanced Hairy Cell LeukemiaMedImmune LLCPhase 3 Completed80 enrolled 32 charts 1 FDA
NCT00586924 2019-04-02A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell LeukemiaMedImmune LLCPhase 1 Completed49 enrolled 40 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts